RLI.NYSERli CORP

Form 4: RLI Corp COO Jennifer Klobnak Receives Stock Options

Sentiment:

Statement of Changes in Beneficial Ownership


RLI Corp Chief Operating Officer Jennifer L. Klobnak was granted 12,500 stock options with an exercise price of $49.88.

Summary

  • Jennifer L. Klobnak, Chief Operating Officer of RLI Corp, was granted 12,500 stock options on May 14, 2026.
  • The options have an exercise price of $49.88 per share.
  • The options vest at a rate of 20% per year, beginning one year from the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral in terms of immediate market impact.

Positives

  • Alignment of executive interests with long-term shareholder value through equity-based compensation.

Negatives

  • Potential for future dilution of existing shareholders upon the exercise of these options.

Risks

  • Market price volatility affecting the value of the granted options.
  • Performance-based vesting requirements may not be met if company or individual targets are not achieved.

Future Outlook

The options vest in 20% annual increments over five years, incentivizing long-term retention and performance through May 2034.

Management Comments

  • No specific management commentary provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that equity grants to C-suite executives are standard practice in the insurance industry to ensure leadership remains focused on long-term underwriting profitability and capital management.

Comparison to Industry Standards

  • The vesting schedule of 20% per year is consistent with standard corporate governance practices for executive compensation in the U.S. insurance sector.
  • The use of stock options as a retention tool is common among peers such as Chubb, Markel, and W.R. Berkley.

Stakeholder Impact

  • Shareholders may experience minor dilution if options are exercised in the future.

Next Steps

  • Vesting of the first 20% of options on May 14, 2027.

Key Dates

DateDescription
05/14/2026Date of grant for the stock options.
05/14/2027Initial vesting date for the first 20% of the options.
05/14/2034Expiration date of the stock options.

Keywords

RLI, Insider Trading, Stock Options, Executive Compensation, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.